Blogs

blog_1.jpg

Around the Interwebs—Week of October 26, 2014

By Michelle Werts posted 10-30-2014 13:36

  

Quantitative data for genetic toxicity assessments, safe Gulf shrimp, and a vaccine for nicotine addiction are the diverse research findings and activities being reported on this week. 

SOT Member Research
A new international collaborative study led by George Johnson and featuring contributions by Lya G. Soeteman-Hernández, B. Bhaskar Gollapudi, Kerry L. Dearfield, James T. MacGregor, Lynn H. Pottenger, Chadwick M. Thompson, and Errol Zeiger is the “Editor’s Choice” and on the cover of this month’s edition of Environmental and Molecular Mutagenesis. The study identifies a preferred approach for determining genetic toxicity points of departure, offering quantitative data for use in human health risk assessments and resultant regulatory decision making.

SOT Members in the News
Shrimp_close_up,_Louisiana_(5984945000).jpg“Louisiana shrimp safe to eat after BP Gulf of Mexico spill, local study says” read a recent headline from The New Orleans Times-Picayune. The referenced study was by Jeff Wickliffe, Mark Wilson, and Bridget Simon, among others, who studied shrimp consumption among Vietnamese-American communities in Southeast Louisiana and compared it to the levels of polycyclic aromatic hydrocarbons in Gulf shrimp after the oil spill. The research found no acute health risks or excess cancer risk associated with consumption of the shrimp.

As reported by Virginia Tech News, Marion F.  Ehrich is working with colleagues at Virginia Tech and the University of Minnesota to make a vaccination for nicotine addiction a reality. As envisioned by the researchers, the vaccine would block the pleasure response associated with nicotine consumption with the help of biodegradable nanoparticles.

Science and Public Health News

To stay abreast of these types of items throughout the week, be sure you “like” SOT on Facebook and “follow” SOT on Twitter.

Have news or research you want featured in the future? Send me an email.

0 comments
0 views